FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants - FDA.gov
fda.govSubmitted by fdagov3951 in business
The agency is advising the public, including healthcare providers, of the possible risks that probiotic products pose to preterm infants in hospital settings.